Title : Inhibition of carrier-mediated uptake of epirubicin reduces cytotoxicity in primary culture of rat hepatocytes.

Pub. Date : 2008 Apr

PMID : 17604344






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp). Epirubicin ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
2 Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp). Epirubicin ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
3 Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp). Epirubicin ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus
4 Epirubicin, an antineoplastic drug, is considered to be taken up by tumor cells via a common carrier by facilitated diffusion and is then pumped out in an energy-dependent manner because epirubicin is a substrate for P-glycoprotein (P-gp). Epirubicin ATP-binding cassette, subfamily B (MDR/TAP), member 1B Rattus norvegicus